Risk of central nervous system metastasis and survival in HER2+ positive breast and non-breast cancers
Patients with non-breast cancer HER2+ STs had higher risk of CNS metastasis and poorer OS compared to HER2+ breast cancer patients, with lower utilization of HER2-directed therapy.
Authors
- Adam Barsouk (ORCID: https://orcid.org/0000-0003-2333-7530)
- Austin Yang
- Reema Patel (ORCID: https://orcid.org/0000-0002-0538-5443)
- Julia Shapiro (ORCID: https://orcid.org/0000-0002-5521-2284)
- John S. Wang (ORCID: https://orcid.org/0000-0002-7191-0437)
- Omar Elghawy (ORCID: https://orcid.org/0000-0002-0786-8035)
- Sharon Wald
- Varinder Kaur (ORCID: https://orcid.org/0000-0002-6480-7204)
- Lauren Reed-Guy
- Jessica Xu (ORCID: https://orcid.org/0000-0003-2587-9587)
- Jonathan Sussman (ORCID: https://orcid.org/0000-0002-3057-3550)
Institutions
- Northwestern University (US)
- University of Virginia Health System (US)
- Hospital of the University of Pennsylvania (US)
- University of Virginia (US)
Publication Details
- Journal
- Neuro-Oncology Practice
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1093/nop/npaf057
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00